Ligand Pharmaceuticals
LGND
#3601
Rank
A$5.47 B
Marketcap
A$278.32
Share price
-1.93%
Change (1 day)
42.69%
Change (1 year)

Ligand Pharmaceuticals (LGND) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : A$0.79 Billion

According to Ligand Pharmaceuticals's latest financial reports the company's total liabilities are A$0.79 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Ligand Pharmaceuticals - Total liabilities on balance sheet (from 2001 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31A$0.17 B41.3%
2023-12-31A$0.12 B-47.81%
2022-12-31A$0.24 B-63.06%
2021-12-31A$0.65 B-22.59%
2020-12-31A$0.84 B-18.32%
2019-12-31A$1.03 B4.61%
2018-12-31A$0.99 B207.33%
2017-12-31A$0.32 B0.99%
2016-12-31A$0.32 B3.11%
2015-12-31A$0.31 B8.75%
2014-12-31A$0.28 B362.12%
2013-12-31A$61.77 M-17.46%
2012-12-31A$74.84 M-31.73%
2011-12-31A$0.10 B38.48%
2010-12-31A$79.15 M-48.49%
2009-12-31A$0.15 B-40.36%
2008-12-31A$0.25 B56.28%
2007-12-31A$0.16 B-56.48%
2006-12-31A$0.37 B-34.77%
2005-12-31A$0.58 B10.24%
2004-12-31A$0.52 B11.4%
2003-12-31A$0.47 B32.32%
2002-12-31A$0.35 B4.05%
2001-12-31A$0.34 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
Amgen
AMGN
A$121.22 B 15,190.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Spectrum Pharmaceuticals
SPPI
A$0.12 B-84.64%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
A$92.26 B 11,537.73%๐Ÿ‡ฌ๐Ÿ‡ง UK
Merck
MRK
A$116.88 B 14,643.42%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$174.08 B 21,858.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$137.12 B 17,196.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$117.86 B 14,766.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Baxter
BAX
A$20.85 B 2,530.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
A$170.93 B 21,460.73%๐Ÿ‡บ๐Ÿ‡ธ USA